The goal of this study is to determine the safety and tolerability of KarXT.
The purpose of the Light Study is to evaluate the safety and tolerability of KarXT in males and females with severe renal impairment.
KarXT is being developed for multiple clinical indications including the treatment of psychosis and cognitive impairment.
Participation in the study requires an overnight stay in the Nucleus Network Clinic.
This study has been approved by an independent ethics committee.
Reimbursement for study participation will be provided for time and travel of up to $2,775.
Call Tyler at 612-368-6967 or register your interest to discuss your eligibility today!
Transportation maybe arranged to and from the clinic for appointments.